Auf dieser Seite
FEMY Femasys Inc. - Common Stock
NASDAQ · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 14, 2026
$2,05
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$0,3352-Wochen-Tief
$7,6052-Wochen-Hoch
Marktkapitalisierung (MRQ)
$6M
P/E (TTM)
-1.5
EPS (TTM)
$-1.41
Umsatz (TTM)
$2M
Ihre Abzeichen
52W-Spanne
$0–$8
Analystenbewertung
BUY
Kursziel
$14
P/E
-1.5
ROE
-425.0%
Nettogewinnmarge
-511.8%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
FEMY Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.05
Marktkapitalisierung (MRQ)
$6M
P/E (TTM)
-1.5
EPS (TTM)
$-1.41
Umsatz (TTM)
$2M
ROE (TTM)
-425.0%
52W-Spanne
$0–$8
FEMY Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 8. Juni 2026 | 1-for-20 | Umgekehrt |
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$2M2020-12-31 → 2025-12-31
EPS$-0.472020-12-31 → 2025-12-31
Freier Cashflow$-19M2021-12-31 → 2025-12-31
Nettogewinnmarge-511.8%2021-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | FEMY | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -1.55-Jahres-Durchschnitt ≈-1.6 | ≈-1.6 | · | · | |
| P/S (TTM) | 2.75-Jahres-Durchschnitt ≈19.7 | ≈19.7 | 5.5 | Fairer Wert | |
| K/B (MRQ) | 1.55-Jahres-Durchschnitt ≈4.9 | ≈4.9 | 2.4 | Überbewertet | |
| Kurs / FCF (TTM) | -0.35-Jahres-Durchschnitt ≈-2.4 | ≈-2.4 | · | · | |
| Kurs / Cashflow (TTM) | -0.45-Jahres-Durchschnitt ≈-2.5 | ≈-2.5 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 1.65-Jahres-Durchschnitt ≈4.2 | ≈4.2 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | FEMY | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -763.9%5-Jahres-Durchschnitt ≈-881.8% | ≈-881.8% | -683.4% | Schwach | |
| EBITDA Margin (EBITDA-Marge) | -767.0%5-Jahres-Durchschnitt ≈-881.8% | ≈-881.8% | -683.4% | Schwach | |
| Vorgewinnmarge (TTM) | -511.5%5-Jahres-Durchschnitt ≈-887.3% | ≈-887.3% | -654.7% | Schwach | |
| Nettogewinnmarge (TTM) | -511.8%5-Jahres-Durchschnitt ≈-887.7% | ≈-887.7% | -655.0% | Schwach | |
| ROA (TTM) | -90.3%5-Jahres-Durchschnitt ≈-74.4% | ≈-74.4% | -65.1% | Unterdurchschnittlich | |
| ROE (TTM) | -425.0%5-Jahres-Durchschnitt ≈-264.0% | ≈-264.0% | -176.9% | Schwach | |
| ROIC | -299.7%5-Jahres-Durchschnitt ≈-294.7% | ≈-294.7% | -64.2% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | FEMY | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 2.15-Jahres-Durchschnitt ≈7.5 | ≈7.5 | 2.1 | Im Einklang | |
| Quick Ratio | 2.75-Jahres-Durchschnitt ≈6.6 | ≈6.6 | 0.9 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | FEMY | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 40.8%5-Jahres-Durchschnitt ≈19.5% | ≈19.5% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 23.9%5-Jahres-Durchschnitt ≈12.1% | ≈12.1% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 17.2% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | FEMY | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.15-Jahres-Durchschnitt ≈0.1 | ≈0.1 | 0.2 | Schwach | |
| Inventory Turnover (Lagerumschlag) | 0.25-Jahres-Durchschnitt ≈1.0 | ≈1.0 | 2.6 | Schwach | |
| Receivables Turnover (Forderungsumschlag) | 4.25-Jahres-Durchschnitt ≈9.0 | ≈9.0 | 4.6 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$45.0K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
15.6%
Nächster Bericht
Nov 12, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 14, 2026 | $-1.55 | $-1.33 | -16.9% |
| 31. März 2026 | Mai 7, 2026 | $-1.20 | $-1.84 | 34.6% |
| 31. Dezember 2025 | $-0.20 | $-1.78 | 88.8% | |
| 30. September 2025 | $-2.00 | $-2.65 | 24.6% | |
| 30. Juni 2025 | $-3.00 | $-3.67 | 18.3% | |
| 31. März 2025 | $-0.23 | $-0.19 | -18.7% | |
| 31. Dezember 2024 | $-0.23 | $-0.19 | -21.9% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $2M | $2M | $1M | $1M | $1M | $1M | |
| Cost of Revenue | $872.4K | $544.9K | $380.1K | $441.9K | $370.4K | $306.5K | |
| Gross Profit | · | · | · | $764.3K | $809.3K | $731.4K | |
| R&D Expense | $8M | $8M | $7M | $6M | $4M | $4M | |
| SG&A Expense | $7M | $6M | $7M | $5M | $4M | $3M | |
| Operating Expenses | $19M | $19M | $15M | $12M | $9M | $8M | |
| Operating Income | $-18M | $-18M | $-15M | $-12M | $-8M | $-7M | |
| Interest Expense | · | · | $165.4K | $13.5K | $19.2K | $12.6K | |
| Interest Income | $101.8K | $582.4K | $431.0K | · | · | · | |
| Other Non-op | $-482.6K | $0 | $265.6K | $212.4K | $803.0K | $20.0K | |
| Pretax Income | $-19M | $-19M | $-14M | $-11M | $-8M | $-7M | |
| Income Tax | $1.3K | $9.6K | $4.3K | $6.3K | $4.0K | $1.8K | |
| Net Income | $-19M | $-19M | $-14M | $-11M | $-8M | $-7M | |
| EPS (Basic) | $-0.47 | $-0.85 | $-0.93 | $-0.96 | $-1.12 | $-7.20 | |
| EPS (Diluted) | $-0.47 | $-0.85 | $-0.93 | $-0.96 | $-1.12 | $-7.20 | |
| Shares (Basic) | 39,549,218 | 22,267,695 | 15,384,376 | 11,815,019 | 6,712,028 | 959,862 | |
| Shares (Diluted) | 39,549,218 | 22,267,695 | 15,384,376 | 11,815,019 | 6,712,028 | 959,862 | |
| EBITDA | $-18M | $-18M | · | $-12M | $-8M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $3M | $22M | $13M | $25M | $3M | |
| Receivables | $616.6K | $488.4K | $98.9K | $77.5K | $84.3K | $125.8K | |
| Inventory | $6M | $3M | $667.1K | $436.7K | $208.3K | $131.4K | |
| Other Current Assets | $833.1K | $1M | $695.9K | $655.4K | $555.9K | $284.1K | |
| Current Assets | $16M | $8M | $23M | $14M | $26M | $4M | |
| PP&E (Net) | $2M | $2M | $1M | $1M | $2M | $2M | |
| PP&E (Gross) | $6M | $5M | $5M | $5M | $4M | $4M | |
| Accum. Depreciation | $4M | $4M | $4M | $3M | $3M | $2M | |
| Intangibles | $134.9K | $65.9K | $0 | $3.3K | $25.1K | $65.1K | |
| Other Non-current Assets | $940.2K | $955.0K | $1M | $958.2K | $655.4K | $792.4K | |
| Total Assets | $21M | $12M | $28M | $17M | $29M | $8M | |
| Accounts Payable | $2M | $1M | $1M | $510.8K | $445.5K | $674.3K | |
| Accrued Liabilities | $1M | $1M | $1M | $456.7K | $603.8K | $1M | |
| Short-term Debt | · | $0 | $0 | $141.3K | $181.1K | $630.0K | |
| Current Liabilities | $4M | $9M | $3M | $2M | $2M | $3M | |
| Capital Leases | $1M | $2M | $2M | $28.6K | $386.2K | $769.8K | |
| Other Non-current Liabilities | · | · | · | · | $0 | $32.9K | |
| Total Liabilities | $15M | $10M | $9M | $2M | $2M | $4M | |
| Total Debt | · | · | · | $141.3K | $181.1K | · | |
| Common Stock | $3.0K | $23.5K | $21.8K | $12.0K | $11.9K | $1.1K | |
| Paid-in Capital | $147M | $128M | $124M | $109M | $108M | $23M | |
| Retained Earnings | $-146M | $-127M | $-108M | $-94M | $-83M | $-75M | |
| Treasury Stock | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | |
| AOCI | · | · | · | · | $0 | $0 | |
| Stockholders' Equity | $6M | $2M | $18M | $15M | $26M | $-52M | |
| Liabilities + Equity | $21M | $12M | $28M | $17M | $29M | $8M | |
| Shares Outstanding | 2,980,254 | 23,355,926 | 21,657,381 | 11,869,704 | 11,804,165 | 993,124 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $342.0K | $297.3K | $483.5K | $561.2K | $591.1K | $679.7K | |
| Stock-based Comp | $790.1K | $444.1K | $675.7K | $224.9K | $193.4K | $318.6K | |
| Deferred Tax | $-4M | $0 | $0 | $0 | $-2M | · | |
| Amort. of Intangibles | $46.2K | $20.1K | $3.3K | $21.8K | $40.0K | $118.9K | |
| Operating Cash Flow | $-19M | $-19M | $-11M | $-11M | $-8M | $-5M | |
| CapEx | $525.0K | $761.7K | $143.9K | $407.5K | $306.9K | $8.4K | |
| Investing Cash Flow | $-630.1K | $-847.8K | $-143.9K | $-407.5K | $-306.9K | $968.3K | |
| Stock Issued | · | $2M | $8M | $59.6K | $32M | $153.2K | |
| Stock Repurchased | · | $60.8K | $230.0K | $0 | · | · | |
| Net Stock Activity | · | $2M | · | $79.5K | $32M | · | |
| Financing Cash Flow | $25M | $2M | $20M | $-681.6K | $30M | $871.6K | |
| Taxes Paid | $6.8K | $5.7K | $4.5K | $5.0K | $800 | $2.0K | |
| Free Cash Flow | $-19M | $-20M | · | $-11M | $-8M | · | |
| Levered FCF | · | · | · | $-11M | $-8M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | 63.4% | 68.6% | · | |
| Operating Margin | -767.0% | -1091.8% | · | -961.7% | -706.7% | · | |
| Net Margin | -812.3% | -1155.0% | · | -944.6% | -639.0% | · | |
| Pretax Margin | -812.2% | -1154.4% | · | -944.1% | -638.6% | · | |
| EBITDA Margin | -767.0% | -1091.8% | · | -961.7% | -706.7% | · | |
| ROA | -112.3% | -93.6% | · | -50.1% | -41.7% | · | |
| ROE | -505.0% | -454.8% | · | -68.5% | -27.4% | · | |
| ROIC | -299.7% | -772.2% | · | -75.4% | -31.5% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 0.9 | · | 9.2 | 15.1 | · | |
| Quick Ratio | 2.7 | 0.5 | · | 8.5 | 14.7 | · | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | · | |
| Interest Coverage | · | · | · | -861.6 | -433.6 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | · | |
| Inventory Turnover | 0.2 | 0.3 | · | 1.4 | 2.2 | · | |
| Receivables Turnover | 4.2 | 5.5 | · | 14.9 | 11.2 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.10 | $0.10 | · | $1.28 | $2.23 | · | |
| Revenue / Share | $0.06 | $0.07 | · | $0.10 | $0.18 | · | |
| Cash Flow / Share | $-0.47 | $-0.87 | · | $-0.91 | $-1.18 | · | |
| Cash / Share | $0.16 | $0.15 | · | $1.09 | $2.10 | · | |
| EPS (TTM) | $-0.47 | $-0.85 | $-0.93 | $-0.96 | $-1.12 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 40.8% | 52.0% | -11.1% | 2.2% | 13.7% | · | |
| Revenue CAGR 3Y | 23.9% | 11.4% | 1.1% | · | · | · | |
| Revenue CAGR 5Y | 17.2% | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | $1M | $1M | $1M | · | |
| Net Income TTM | $-19M | $-19M | $-14M | $-11M | $-8M | · | |
| Market Cap | $34M | $26M | · | $11M | $46M | · | |
| Enterprise Value | · | · | · | $-2M | $21M | · | |
| P/E | -1.2 | -1.3 | -1.0 | -0.9 | -3.5 | · | |
| P/S | 15.0 | 15.8 | · | 8.9 | 39.0 | · | |
| P/B | 5.8 | 11.1 | · | 0.7 | 1.7 | · | |
| P / Tangible Book | 6.0 | 11.5 | 1.2 | 0.7 | 1.7 | · | |
| P / Cash Flow | -1.8 | -1.3 | · | -1.0 | -5.8 | · | |
| P / FCF | -1.8 | -1.3 | · | -1.0 | -5.6 | · | |
| EV / EBITDA | · | · | · | 0.2 | -2.6 | · | |
| EV / FCF | · | · | · | 0.2 | -2.6 | · | |
| EV / Revenue | · | · | · | -1.8 | 18.2 | · | |
| Earnings Yield | -81.6% | -77.3% | -95.4% | -106.7% | -28.7% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $331.8K | $424.9K | $813.4K | $729.4K | $409.3K | $341.3K | $581.6K | $554.9K | $221.5K | $271.1K | $213.1K | $244.4K | $320.5K | $294.0K | $234.2K | $347.5K | |
| Cost of Revenue | $142.4K | $158.6K | $303.1K | $293.8K | $158.2K | $117.3K | $192.4K | $190.8K | $73.1K | $88.5K | $78.3K | $86.2K | $110.5K | $105.1K | $85.5K | $131.5K | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | · | $158.2K | $210.0K | $188.9K | · | $216.0K | |
| R&D Expense | $2M | $1M | $2M | $1M | $1M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | |
| SG&A Expense | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | |
| Operating Expenses | $5M | $4M | $5M | $4M | $4M | $6M | $5M | $5M | $5M | $4M | $5M | $4M | $3M | $3M | $3M | $3M | |
| Operating Income | $-5M | $-4M | $-5M | $-4M | $-4M | $-5M | $-5M | $-5M | $-4M | $-3M | $-4M | $-4M | $-3M | $-3M | $-3M | $-3M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $361.6K | · | $8.0K | $198 | $1.7K | $3.8K | $6.0K | |
| Interest Income | $19.7K | $49.8K | $48.3K | $17.3K | $17.1K | $19.0K | $49.5K | $124.0K | $184.1K | $224.7K | $198.9K | $92.4K | $42.7K | · | · | · | |
| Other Non-op | $0 | $5M | $244.2K | $-26.3K | $-260.0K | $-440.4K | $136.9K | $0 | $0 | $-136.9K | $43.4K | $84.4K | $42.5K | $95.4K | $112.5K | $74.3K | |
| Pretax Income | $-4M | $846.1K | $-4M | $-4M | $-5M | $-6M | $-5M | $-5M | $-5M | $-4M | $-4M | $-4M | $-3M | · | · | · | |
| Income Tax | $865 | $0 | $5.5K | $0 | $0 | $-4.2K | $10.2K | $1.2K | $-1.8K | $0 | $4.3K | $0 | $0 | · | · | · | |
| Net Income | $-4M | $846.1K | $-4M | $-4M | $-5M | $-6M | $-5M | $-5M | $-5M | $-4M | $-4M | $-4M | $-3M | $-3M | $-3M | $-3M | |
| EPS (Basic) | $-1.33 | $0.00 | $0.02 | $-0.10 | $-3.18 | $-0.23 | $-0.23 | $-0.24 | $-0.21 | $-0.17 | $-0.20 | $-0.26 | $-0.22 | $-0.25 | $-0.25 | $-0.25 | |
| EPS (Diluted) | $-1.33 | $0.00 | $0.02 | $-0.10 | $-3.18 | $-0.23 | $-0.23 | $-0.24 | $-0.21 | $-0.17 | $-0.20 | $-0.26 | $-0.22 | $-0.25 | $-0.25 | $-0.25 | |
| Shares (Basic) | 3,357,117 | 66,645,591 | · | 41,015,196 | 1,444,036 | 25,149,236 | · | 22,232,799 | 22,215,516 | 21,775,357 | · | 15,093,147 | 13,107,590 | 11,872,255 | · | 11,813,610 | |
| Shares (Diluted) | 3,357,117 | 78,095,633 | · | 41,015,196 | 1,444,036 | 25,149,236 | · | 22,232,799 | 22,215,516 | 21,775,357 | · | 15,093,147 | 13,107,590 | 11,872,255 | · | 11,813,610 | |
| EBITDA | $-5M | $-4M | · | $-4M | $-4M | $-5M | · | $-5M | $-4M | $-3M | · | $-4M | $-3M | $-3M | · | $-3M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1M | $5M | $9M | $5M | $3M | $4M | $3M | $8M | $14M | $18M | $22M | $9M | $11M | $10M | $13M | $16M | |
| Receivables | $151.0K | $172.3K | $616.6K | $572.2K | $254.6K | $233.6K | $488.4K | $378.3K | $92.5K | $120.5K | $98.9K | $103.6K | $155.7K | $124.0K | $77.5K | $183.1K | |
| Inventory | $6M | $6M | $6M | $6M | $5M | $4M | $3M | $2M | $1M | $971.3K | $667.1K | $602.7K | $581.5K | $500.7K | $436.7K | $343.1K | |
| Other Current Assets | $546.1K | $679.9K | $833.1K | $1M | $1M | $1M | $1M | $1M | $997.6K | $955.5K | $695.9K | $826.4K | $587.8K | $542.1K | $655.4K | $760.6K | |
| Current Assets | $8M | $12M | $16M | $12M | $10M | $9M | $8M | $11M | $16M | $20M | $23M | $10M | $12M | $11M | $14M | $17M | |
| PP&E (Net) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | |
| PP&E (Gross) | $6M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Accum. Depreciation | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | |
| Intangibles | $115.5K | $124.3K | $134.9K | $130.0K | $55.6K | $58.7K | $65.9K | $70.1K | $44.3K | $33.1K | $0 | $388 | $970 | $1.9K | $3.3K | $5.8K | |
| Other Non-current Assets | $918.6K | $924.6K | $940.2K | $744.8K | $829.2K | $838.0K | $955.0K | $887.4K | $957.1K | $1M | $1M | $937.0K | $865.6K | $920.8K | $958.2K | $789.6K | |
| Total Assets | $12M | $16M | $21M | $16M | $14M | $13M | $12M | $16M | $20M | $24M | $28M | $15M | $14M | $14M | $17M | $20M | |
| Accounts Payable | $2M | $2M | $2M | $2M | $3M | $2M | $1M | $1M | $951.5K | $1M | $1M | $851.9K | $546.9K | $526.8K | $510.8K | $419.1K | |
| Accrued Liabilities | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $886.4K | $673.5K | $1M | $569.4K | $536.8K | $535.4K | $456.7K | $649.6K | |
| Short-term Debt | · | · | · | $276.5K | · | · | · | · | · | · | · | $283.3K | $0 | $0 | $141.3K | $280.6K | |
| Current Liabilities | $4M | $3M | $4M | $11M | $11M | $10M | $9M | $3M | $2M | $2M | $3M | $2M | $1M | $1M | $2M | $2M | |
| Capital Leases | $796.0K | $912.5K | $1M | $1M | $1M | $1M | $2M | · | · | · | $2M | · | · | · | $28.6K | · | |
| Total Liabilities | $8M | $9M | $15M | $12M | $12M | $11M | $10M | $10M | $9M | $9M | $9M | $4M | $1M | $2M | $2M | $2M | |
| Total Debt | · | · | · | $276.5K | · | · | · | · | · | · | · | $283.3K | $0 | $0 | · | $280.6K | |
| Common Stock | $3.0K | $60.5K | $59.7K | $47.4K | $32.7K | $27.2K | $23.5K | $22.4K | $22.4K | $22.2K | $21.8K | $16.1K | $15.2K | $12.0K | $12.0K | $11.9K | |
| Paid-in Capital | $148M | $147M | $146M | $140M | $137M | $133M | $128M | $125M | $125M | $125M | $124M | $113M | $111M | $109M | $109M | $109M | |
| Retained Earnings | $-149M | $-145M | $-146M | $-142M | $-138M | $-133M | $-127M | $-122M | $-117M | $-112M | $-108M | $-104M | $-100M | $-97M | $-94M | $-91M | |
| Treasury Stock | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | $60.0K | |
| Stockholders' Equity | $4M | $7M | $6M | $5M | $2M | $2M | $2M | $6M | $11M | $16M | $18M | $10M | $13M | $12M | $15M | $18M | |
| Liabilities + Equity | $12M | $16M | $21M | $16M | $14M | $13M | $12M | $16M | $20M | $24M | $28M | $15M | $14M | $14M | $17M | $20M | |
| Shares Outstanding | 3,023,967 | 60,390,686 | 59,602,787 | 47,302,373 | 32,575,407 | 27,087,886 | 23,355,926 | 22,232,799 | 22,232,799 | 22,099,347 | 21,657,381 | 15,992,869 | 15,073,153 | 11,872,573 | 11,869,704 | 11,813,610 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $82.8K | $82.3K | $85.2K | $85.7K | $86.3K | $84.9K | $82.2K | $76.3K | $67.6K | $71.2K | $91.8K | $125.3K | $133.3K | $133.1K | $134.8K | $139.6K | |
| Stock-based Comp | $210.8K | $151.6K | $66.4K | $174.5K | $182.0K | $367.2K | $134.1K | $128.4K | $104.0K | $77.6K | $49.2K | $504.4K | $65.2K | $57.0K | $66.7K | $51.8K | |
| Amort. of Intangibles | $19.0K | $16.7K | $16.7K | $13.7K | $8.6K | $7.2K | $8.0K | $6.3K | $4.6K | $1.2K | $388 | $581 | $912 | $1.4K | $2.5K | $4.8K | |
| Operating Cash Flow | $-4M | $-4M | $-4M | $-5M | $-4M | $-5M | $-5M | $-5M | $-4M | $-5M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | |
| CapEx | $9.4K | $79.1K | $139.8K | $194.3K | $94.2K | $96.6K | $106.8K | $407.9K | $182.4K | $64.6K | $44.9K | $27.2K | $62.9K | $8.9K | $93.9K | $18.5K | |
| Investing Cash Flow | $-22.2K | $-79.1K | $-196.7K | $-239.8K | $-97.0K | $-96.6K | $-110.6K | $-440.0K | $-207.0K | $-90.2K | $-44.9K | $-27.2K | $-62.9K | $-8.9K | $-93.9K | $-18.5K | |
| Stock Issued | · | · | · | · | $-882.0K | $5M | · | $-8M | $-802.2K | $802.2K | $8M | $0 | $0 | $3.4K | $59.6K | $-16.2K | |
| Stock Repurchased | · | · | · | · | · | $161.8K | · | $0 | $6.6K | $24.1K | $230.0K | $0 | $0 | $0 | · | · | |
| Net Stock Activity | · | · | · | · | · | $5M | · | · | · | $778.2K | · | · | · | $3.4K | · | · | |
| Financing Cash Flow | $15.3K | $342.3K | $9M | $7M | $4M | $5M | $1M | $0 | $223.5K | $778.2K | $16M | $870.3K | $3M | $-144.1K | $-82.0K | $-362.0K | |
| Taxes Paid | $-5.5K | $0 | $800 | $0 | $6.0K | $0 | $0 | $1.2K | · | · | $0 | $4.5K | $0 | $0 | $0 | $4.2K | |
| Free Cash Flow | · | $-4M | · | · | · | $-5M | · | · | · | $-5M | · | · | · | $-3M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | · | · | · | 64.7% | 65.5% | 64.2% | · | 62.2% | |
| Operating Margin | -1526.7% | -994.0% | · | -500.9% | -941.1% | -1600.1% | · | -922.4% | -2023.7% | -1277.1% | · | -1670.2% | -916.0% | -1034.6% | · | -879.9% | |
| Net Margin | -1346.8% | 199.1% | · | -575.1% | -1120.5% | -1727.9% | · | -974.7% | -2115.1% | -1327.5% | · | -1635.7% | -902.8% | -1002.2% | · | -858.5% | |
| Pretax Margin | -1346.5% | 199.1% | · | -575.1% | -1120.5% | -1729.2% | · | -974.5% | -2115.9% | · | · | · | · | · | · | · | |
| EBITDA Margin | -1526.7% | -994.0% | · | -500.9% | -941.1% | -1600.1% | · | -922.4% | -2023.7% | -1277.1% | · | -1670.2% | -916.0% | -1034.6% | · | -879.9% | |
| ROA | -34.3% | 5.7% | · | -26.3% | -26.9% | -31.3% | · | -35.5% | -27.1% | -18.8% | · | -22.9% | -15.5% | -15.0% | · | -11.7% | |
| ROE | -161.4% | 18.2% | · | -79.7% | -71.9% | -67.0% | · | -65.9% | -38.8% | -25.7% | · | -28.1% | -17.1% | -16.4% | · | -12.8% | |
| ROIC | -125.7% | -57.9% | · | -75.6% | -255.5% | -273.3% | · | -85.8% | -39.8% | · | · | · | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 3.9 | · | 1.2 | 0.9 | 0.9 | · | 3.9 | 6.5 | 8.4 | · | 4.7 | 8.7 | 8.0 | · | 9.6 | |
| Quick Ratio | 0.4 | 1.8 | · | 0.5 | 0.3 | 0.4 | · | 2.8 | 5.5 | 7.6 | · | 4.0 | 7.9 | 7.3 | · | 9.0 | |
| Debt / Equity | · | · | · | 0.1 | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -9.6 | · | -508.1 | -14828.1 | -1819.2 | · | -509.1 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Inventory Turnover | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | 0.3 | 0.3 | · | 0.5 | |
| Receivables Turnover | 1.6 | 2.1 | · | 1.5 | 2.4 | 1.9 | · | 2.3 | 1.8 | 2.2 | · | 1.7 | 2.4 | 2.0 | · | 2.1 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.33 | $0.12 | · | $0.10 | $0.05 | $0.07 | · | $0.27 | $0.51 | $0.71 | · | $0.65 | $0.85 | $1.04 | · | $1.52 | |
| Revenue / Share | $0.10 | $0.01 | · | $0.02 | $0.01 | $0.01 | · | $0.03 | $0.01 | $0.01 | · | $0.02 | $0.02 | $0.02 | · | $0.03 | |
| Cash Flow / Share | · | $-0.05 | · | · | · | $-0.19 | · | · | · | $-0.21 | · | · | · | $-0.22 | · | · | |
| Cash / Share | $0.48 | $0.09 | · | $0.10 | $0.10 | $0.14 | · | $0.34 | $0.61 | $0.81 | · | $0.54 | $0.71 | $0.86 | · | $1.35 | |
| EPS (TTM) | $-1.41 | $-3.26 | · | $-3.74 | $-3.88 | $-0.91 | · | $-0.82 | $-0.84 | $-0.85 | · | $-0.98 | $-0.97 | $-0.97 | · | $0.72 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | · | $2M | $2M | $2M | · | $1M | $950.1K | $1M | · | $1M | $1M | $1M | · | $1M | |
| Net Income TTM | $-12M | $-12M | · | $-20M | $-21M | $-21M | · | $-18M | $-17M | $-15M | · | $-13M | $-12M | $-11M | · | $-11M | |
| Market Cap | $13M | $25M | · | $17M | $31M | $34M | · | $25M | $25M | $34M | · | $48M | $8M | $13M | · | $13M | |
| Enterprise Value | · | · | · | $12M | · | · | · | · | · | · | · | $39M | $-3M | $3M | · | $-2M | |
| P/E | -3.0 | -0.1 | · | -0.1 | -0.2 | -1.4 | · | -1.4 | -1.4 | -1.8 | · | -3.0 | -0.5 | -1.1 | · | 1.6 | |
| P/S | 5.5 | 10.7 | · | 8.1 | 16.7 | 19.9 | · | 19.6 | 26.7 | 32.6 | · | 43.6 | 6.4 | 10.9 | · | 10.9 | |
| P/B | 3.1 | 3.5 | · | 3.7 | 20.9 | 17.0 | · | 4.1 | 2.3 | 2.2 | · | 4.6 | 0.6 | 1.0 | · | 0.7 | |
| P / Tangible Book | 3.2 | 3.5 | · | 3.8 | 21.7 | 17.5 | · | 4.2 | 2.3 | 2.2 | · | 4.6 | 0.6 | 1.0 | · | 0.7 | |
| P / Cash Flow | · | -6.1 | · | · | · | -7.1 | · | · | · | -7.5 | · | · | · | -4.9 | · | · | |
| EV / Revenue | · | · | · | 6.0 | · | · | · | · | · | · | · | 35.9 | -2.5 | 2.3 | · | -1.9 | |
| Earnings Yield | -33.7% | -776.2% | · | -1062.5% | -401.7% | -72.8% | · | -73.9% | -73.7% | -54.8% | · | -32.9% | -190.2% | -89.4% | · | 63.7% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $2M | $2M | $1M | $1M | $1M |
| Bruttogewinnmarge % | · | · | · | 63.4% | 68.6% |
| Betriebsgewinnmarge % | -767.0% | -1091.8% | · | -961.7% | -706.7% |
| Nettoergebnis | $-19M | $-19M | $-14M | $-11M | $-8M |
| Verwässerte EPS | $-0.47 | $-0.85 | $-0.93 | $-0.96 | $-1.12 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | · | · | · | 0.0 | 0.0 |
| Liquiditätsgrad | 4.5 | 0.9 | · | 9.2 | 15.1 |
| Quick Ratio | 2.7 | 0.5 | · | 8.5 | 14.7 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-19M | $-20M | · | $-11M | $-8M |
Institutionelle Eigentümer (13F) 4 Einreicher · $824K gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
4
Gehaltener Wert
$824K
Neue Positionen
0
Geschlossene Positionen
33
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 0 | 33 | 0 | 1 | · |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen. Änderung gegenüber Vorquartal nicht angezeigt: Die Einreicherabdeckung unterscheidet sich zwischen diesen beiden Quartalen zu stark für einen zuverlässigen Vergleich.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $815.360 | 1.415.555 | 98,91% | Aktien |
| Pandora Wealth, Inc. | $8.643 | 15.000 | 1,05% | Aktien |
| IFP Advisors, Inc | $306 | 1.000 | 0,04% | Aktien |
| CX Institutional | $2 | 750 | 0,00% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Nantahala Capital Partners Limited Partnership, Nantahala Capital Management, LLC, Wilmot B. Harkey, Daniel Mack | 17. August 2026 | 9,99% | Erste Einreichung | Passive Anlage | SEC |
| PharmaCyte Biotech, Inc. | 22. November 2023 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 20 Insider · 4 Führungskräfte · 7 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Daniel Scott Currie | Chief Operating Officer | 2. Juni 2025 I | 86.275 | 0 | 0 | $0 |
| Kelley Stinson Nicholas | Chief Commercial Officer | 23. Juni 2025 A | · | 0 | 0 | $0 |
| Christine E Thomas | Chief Reg & Clinical Officer | 28. Januar 2025 A | · | 0 | 0 | $0 |
| Richard D. Spector | Chief Commercial Officer | 12. Februar 2024 A | · | 0 | 0 | $0 |
| Joshua Silverman | Direktor | 25. Juni 2025 A | · | 0 | 0 | $0 |
| Anne Morrissey | Direktor | 21. Juni 2023 A | · | 0 | 0 | $0 |
| Wendy Perrow | Direktor | 21. Juni 2023 A | · | 0 | 0 | $0 |
| Keith J Kendall | Direktor | 14. Juni 2023 A | · | 0 | 0 | $0 |
| John Q Adams JR | Direktor | 8. Juni 2022 A | 239.938 | 0 | 0 | $0 |
| John Dyett | Direktor | 8. Juni 2022 A | 114.709 | 0 | 0 | $0 |
| William Benson Witte | Direktor | 15. Dezember 2021 J | 12.191 | 0 | 0 | $0 |
| Jeffrey Gerald Mifek | · | 7. August 2026 A | 3.125 | 1 | 0 | $10.000 |
| John Charles Canning | · | 7. August 2026 A | 4.375 | 1 | 0 | $14.000 |
| Jeremy Alexander Sipos | · | 7. August 2026 A | 3.125 | 1 | 0 | $10.000 |
| Kathy Lee-Sepsick | · | 7. August 2026 A | 15.625 | 1 | 0 | $50.000 |
| Dov Elefant | · | 7. August 2026 A | 15.625 | 1 | 0 | $50.000 |
| Kenneth D. Eichenbaum | · | 24. Juni 2026 A | · | 0 | 0 | $0 |
| Alistair Milnes | · | 24. Juni 2026 A | · | 0 | 0 | $0 |
| Charles Larsen | · | 24. Juni 2026 A | 56 | 0 | 0 | $0 |
| Edward R Uzialko | · | 24. Juni 2026 A | 30.175 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 2 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
FEMY Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 9 Analysten
KAUF
Median-Ziel
$10.00
+387,8%
2 22,2%
Starker Kauf
6 66,7%
Kauf
1 11,1%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
3 Analysten · 2026-10-02Mittelwert-Ziel $14.33 +599,2%
← Unter allen Zielen
Aktueller Preis $2.05
Tief$10.00
Mittelwert$14.33
Hoch$23.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| FEMY | $34M | -1.2 | 40.8% | -812.3% | -505.0% | · |
| HSCS | · | · | · | · | · | · |
| ICU | · | · | · | · | · | · |
| MODD | $25M | -0.4 | · | · | -260.0% | · |
| SINT | $15M | -0.6 | -64.7% | -1018.1% | -299.7% | 45.3% |
| CTSO | · | -4.9 | 4.1% | · | · | · |
| IRIX | $20M | -4.5 | 8.2% | -8.4% | -80.8% | 36.5% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 14, 2026